International AIDS Society Conference 2013

[June 30 – July 3, 2013]
7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention
Kuala Lumpur, Malaysia
The world’s largest open scientific conference on HIV/AIDS was held Kuala Lumpur, Malaysia. DNDi co-hosted a session on closing the treatment gap for children living with HIV.

A Decade of R&D for Neglected Diseases in Africa

[June 4-5, 2013]
Endemic Country Research and Development for Patient Access
Nairobi, Kenya
On the occasion of DNDi’s 10th anniversary, DNDi and founding partner KEMRI brought together key African decision-makers and public health actors for this special event to explore the challenges and opportunities for research & development for neglected diseases in Africa – past and future!

Grant from UNITAID awarded to bolster development and delivery of child-adapted antiretroviral (ARV) formulation

[Geneva, Switzerland, 11 December 2012]
Grant to help expedite 4-in-1 ARVs adapted for babies and toddlers with HIV/AIDS, including those co-infected with tuberculosis
The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme. The grant, to be disbursed over three years, will enable DNDi and partners to build on the advances made in the field of paediatric HIV to date, and drive specific research and development to deliver child-adapted ARV formulations that do not require refrigeration, are easy-to-administer and palatable, with simplified dosing, and which can be given to children co-infected with tuberculosis.

DNDi Applauds Call for Scale-Up of Pediatric HIV Treatment in US PEPFAR Blueprint for an AIDS-Free Generation

[New York, USA/Geneva, Switzerland – 30 November 30 2012]
Age-appropriate formulations of antiretroviral drugs urgently need to be developed and delivered to save the lives of babies and toddlers living with HIV/AIDS
The Drugs for Neglected Diseases initiative (DNDi) welcomed the US President’s Emergency Plan for AIDS Relief (PEPFAR)’s new ‘PEPFAR Blueprint: Creating an AIDS-Free Generation,’ released by US Secretary of State Hillary Clinton in advance of World AIDS Day, and its focus on ensuring ambitious scale-up of treatment and diagnosis for people with HIV/AIDS, including children living with HIV/AIDS.
Watch “Children living with HIV/AIDS: the reality of a neglected disease”, a short film on the daily life of a mother with an infected child in South Africa

AIDS 2012 – XIX International AIDS Conference

[July 22-27, 2012]
Washington, USA
At the meeting, DNDi co-organized two sessions: one in collaboration with Médecins Sans Frontières (MSF) and Health Global Access Project on “Proposals for a Global Innovation System that Responds to Patients Needs and Ensures both Innovation and Access” and a second one with the International AIDS Society-Industry Liaison Forum (IAS-ILF) on the topic “Catching Children Before They Fall: Addressing Urgent Needs in Developing Drugs for Young Children Living with HIV”.

DNDi and Cipla to Develop 4-in-1 Paediatric Antiretroviral Drug Combination – New formulation to fill the deadly gap in appropriate HIV medicines

[Washington, DC; Geneva; Mumbai – 20 July 2012]
On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announced a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS. Once delivered, this new paediatric ARV combination could help to accelerate the provision of care to the world’s youngest children living with HIV/AIDS, who are at very high risk of dying without treatment. An estimated 3.4 million children have HIV/AIDS, but less than a quarter currently have access to antiretroviral therapy (ART), compared with 54% for adults. Without treatment, more than half of children with HIV/AIDS will die before their second birthday, and 80% will die before they turn five.

Children with HIV/AIDS Falling Through the Cracks of Treatment Scale-Up Efforts

[Geneva, Switzerland/New York, USA – 1 December 2011]
Less than one-quarter (23%) of children with HIV/AIDS who need treatment are getting it, according to a report released by the World Health Organization (WHO) on the occasion of World AIDS Day (1 December 2011). Although treatment coverage for adults has been steadily climbing and has now reached approximately half of those in need, coverage for children is lagging far behind, highlighted the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organization that has recently launched a new paediatric HIV drug development programme.

Elisabeth Glaser Paediatric AIDS Foundation’s Blog [August 19, 2011]
“What we are reading: Peadiatric AIDS as a Neglected Disease”